Home
Mochida Pharmaceutical

Mochida Pharmaceutical Market Share Analysis for June 2026

心の健康に関する疑問や悩みをお持ちですか？『こんな時、どうしたらいいの？』とお困りのあなたに、心理士が回答するQ&Aページです。

Health > Biotechnology and Pharmaceuticals

Domainmochida.co.jp

Year Founded1913

Employees1001 - 5000

Annual Revenue$500M - $1B

Mochida Pharmaceutical

Mochida Pharmaceutical (including company regionals)

mochida.co.jp

See more website traffic and engagement information

Mochida Pharmaceutical Revenue up to June 2026 is 500M - 1B

revenue generated by Mochida Pharmaceutical top domains

Mochida Pharmaceutical top domains revenue over 3 years

Revenue for Mochida Pharmaceutical top domains

mochida.co.jp500M - 1B

See more with Sales Intelligence

Total visits to Mochida Pharmaceutical's top domains

Understand Mochida Pharmaceutical market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

mochida.co.jp221.1K

See more with Sales Intelligence

Avg. visit duration in Mochida Pharmaceutical's top domains

Analyze Mochida Pharmaceutical engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

mochida.co.jp00:01:08

See more with Sales Intelligence

Avg. pageviews on Mochida Pharmaceutical's top domains

See how Mochida Pharmaceutical keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

mochida.co.jp2.15

See more with Sales Intelligence

Mochida Pharmaceutical top competitors by domain

Top similar sites in June 2026, ranked by their affinity

kenei-pharm.comCompany NameKenei PharmaceuticalEmployees501 - 1000HQJapan, OsakaAnnual revenue--Total visits747.8KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Mochida Pharmaceutical

These are the website technologies, by industry, used by Mochida Pharmaceutical top domains

Payment & Currencies (22)

PayPal

Advertising (7)

Google Adsense

Conversion & Analytics (3)

Google Analytics

Email Services (2)

Microsoft Exchange Online

More Technologies

8

See all

News & Signals from Mochida Pharmaceutical

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMochida Pharmaceutical launched Epadel generic version on May 14th '26.Mochida Pharmaceutical, a Japanese pharmaceutical company, has entered the authorized generic market with the launch of an Epadel generic version, according to Nissui financial statements as of May 14, 2026.

NewsMochida Pharmaceutical is developing daridorexant for sleep disorders on May 12th '26.Mochida Pharmaceutical is co-developing daridorexant for sleep disorders with Idorsia, whose shares surged 6.68% to CHF 4.15 on May 12, 2026, on SIX Swiss Exchange, according to Meyka as of 05/12/2026

NewsMochida Pharmaceutical launched DED treatment with TRPV1 antagonistic activity on Apr 30th '26.In comments accompanying the launch, Mochida's head of business development, Tomokazu Matsusue, said, "We are very pleased that the TRPV1 antagonist, which has been researched over many years since its discovery, has now been launched through Senju's extensive development efforts as the world's first DED treatment with TRPV1 antagonistic activity.